`
`(19) i+i Canadian
`Intellectual Property
`Office
`
`Office de la Propri.,t,
`Intellectuelle
`du Canada
`
`(11) CA 2 362 939
`(40) 24.08.2000
`(43) 24.08.2000
`
`(13) A1
`
`An Agency of
`Industry Canada
`
`Un organisme
`d'Industrie Canada
`
`
`
`(12)
`
`(21) 2362939
`
`(22)
`
`18.02.2000
`
`(51)
`
`Int. Cl”:
`
`C12N 15/10, C12P 19/34
`
`(85)
`
`13.08.2001
`
`(86) PCT/EP00/01356
`
`(87) wo00/49142
`D-68167, MANNHEIM, XX (DE).
`
`(30)
`
`199 07 080.6 DE 19.02.1999
`199 28 843.7 DE 24.06.1999
`199 40 752.5 DE 27.08.1999
`PCT/EP99/06316 EP 27.08.1999
`199 57116.3 DE 26.11.1999
`
`(72)
`
`STAHLER,PEER F. (DE).
`STAHLER, CORDF. (DE).
`MULLER, MANFRED (DE).
`
`(71)
`
`FEBIT FERRARIUS BIOTECHNOLOGY GMBH,
`(74)
`
`Kafertalerstrasse 190 SWABEY OGILVY RENAULT
`
`(54)
`(54)
`
`PROCEDE DE PRODUCTION DE POLYMERES
`METHOD FOR PRODUCING POLYMERS
`
`(57)
`
`The invention relates to a method for producing
`polymers,
`especially synthetic
`nucleic
`acid double
`strands of optional sequence, comprising the following
`steps:
`(a) providing a
`support with a surface which
`contains a plurality of
`individual
`reaction zones,
`(b)
`location-resolved synthesis of nucleic acid
`fragments
`with different base sequences respectively in
`several
`of the
`individual
`reaction areas and (c)
`removing the
`nucleic acid fragments
`from the
`individual
`reaction
`areas.
`
`5Ab
`63
`6
`
`
`
`
`
`
`

`

`Office de la Propriété
`+i Intellectuelle
`du Canada
`
`Canadian
`Intellectual Property
`Office
`
`Un organisme
`d'Industrie Canada
`
`An agency of
`Industry Canada
`
`CA 2362939 A1 2000/08/24
`ey 2 362 939
`12) DEMANDE DE BREVET CANADIEN
`CANADIAN PATENT APPLICATION
`a3) At
`
`(86) Date de dépét PCT/PCT Filing Date: 2000/02/18
`
`(87) Date publication PCT/PCT Publication Date: 2000/08/24
`(85) Entrée phase nationale/National Entry: 2001/08/13
`
`(86) N° demande PCT/PCT Application No.: EP 2000/001356
`(87) N° publication PCT/PCT Publication No.: 2000/049142
`(30) Priorités/Priorities: 1999/02/19 (199 07 080.6) DE;
`1999/06/24 (199 28 843.7) DE;
`
`1999/08/27 (199 40 752.5) DE
`1999/08/27 (PCT/EP99/06316) EP;
`1999/11/26 (199 57 116.3) DE
`
`(54) Titre : PROCEDE DE PRODUCTION DE POLYMERES
`(54) Title: METHOD FOR PRODUCING POLYMERS
`
`(61) Cl.nt./Int.Cl.? C12N 15/10, C12P 19/34
`(71) Demandeur/Applicant:
`FEBIT FERRARIUS BICTECHNOLOGY GMBH, DE
`
`(72) Inventeurs/Inventors:
`MULLER, MANFRED, DE;
`STAHLER, CORD F., DE;
`STAHLER, PEER F., DE
`
`(74) Agent: SWABEY OGILVY RENAULT
`
`
`
`
`62
`
`5A\o
`
`
`
`(57) Abrégé/Abstract
`The invention relates to a method for producing polymers, especially synthetic nucleic acid double strands of optional sequence,
`comprising the following steps: (a) providing a support with a surface which contains a plurality of individual reaction zones, (b)
`location-resolved synthesis of nucleic acid fragments with different base sequences respectively in several of the individual
`reaction areas and (c) removing the nucleic acid fragments from the individual reaction areas.
`
`( anada Attp:/fopic.gc.ca» Ottawa-Hull KLA 0C9 + Artp:cipo.ge.ca
`
`OPIC. - CIPO 191
`
`OPIC
`
`

`

`CA 02362939 2001-08-13
`
`-1-
`
`Abstract
`
`acid fragments
`
`from
`
`producing
`for
`a method
`to
`relates
`invention
`The
`polymers,
`in particular synthetic nucleic acid double
`strands of optional sequence, comprising the steps:
`(a)
`provision of a support having a surface area which
`contains a plurality of individual reaction areas,
`location-resolved
`synthesis
`of
`nucleic
`acid
`fragments
`having
`in
`each
`case different
`hbase
`sequences in several of
`the individual
`reaction
`areas, and
`the nucleic
`of
`detachment
`individual reaction areas.
`
`(b)
`
`(c)
`
`

`

`CA 02362939 2001-08-13
`
`Method for producing polymers
`
`Description
`
`The for§producinginvention relates to a method
`
`
`
`
`
`polymers,
`in particular synthetic nucleic acid double
`
`strands of optional sequence.
`
`10
`
`i5
`
`20
`
`25
`
`Technical background of the invention
`Manipulation and construction of genetic elements such
`as,
`for
`example,
`gene
`fragments, whole
`genes
`or
`regulatory regions
`through
`the
`development
`of
`DNA
`recombination technology, which is often also referred
`to as genetic engineering,
`led to a particular need for
`
`genetic engineering methods
`
`and
`
`further
`
`development
`
`thereof
`
`in
`
`the
`
`areas
`
`of
`
`gene
`
`therapy, molecular
`
`medicine (basic research, vector development, vaccines,
`
`regeneration, etc.).
`Important areas of application are
`also the development of active substances, production
`of active substances in the context of the development
`
`biosynthesis
`combinatorial
`pharmaceuticals,
`of
`(antibodies, effectors such as growth factors, neural
`transmitters, etc.), biotechnology (e.g. enzyme design,
`pharming, biological production methods, bioreactors,
`etc.),
`diagnostics
`(BioChips,
`receptors/antibodies,
`enzyme
`design,
`etc.)
`and
`environmental
`technology
`(specialized
`or
`custom microorganisms,
`production
`
`processes, cleaning-up, sensors, etc.).
`
`30
`
`Prior art
`
`Numerous methods,
`first
`and
`foremost
`enzyme-based
`
`
`
`methods, DNA_forallow specific manipulation of
`different purposes.
`
`35
`
`All of
`
`said methods have
`
`to use available genetic
`
`material. Said material
`
`is,
`
`on the one hand, well-
`
`large extent but allows,
`defined to a
`hand,
`in a kind of “construction kit
`
`the other
`on
`system” only a
`
`

`

`CA 02362939 2001-08-13
`
`limited
`amount
`of
`possible
`combinations
`of
`particular available and slightly modified elements.
`
`the
`
`In this connection, completely synthetic DNA has so far
`played only a minor part
`in the form of one of
`these
`combinatorial elements, with the aid of which specific
`
`modifications of
`
`the available genetic material
`
`are
`
`possible.
`
`10
`
`The
`
`known methods
`
`share
`
`the
`
`large
`
`amount
`
`of work
`
`15
`
`20
`
`25
`
`30
`
`35
`
`of
`duration
`certain
`a
`combined with
`required,
`appropriate operations,
`since the stages of molecular
`biological and in particular genetic experiments such
`as DNA isolation, manipulation,
`transfer into suitable
`target
`cells,
`propagation,
`.renewed
`isolation,
`etc.
`usually have to be repeated several
`times. Many of the
`operations which come
`up can only insufficiently be
`automated and accelerated so
`that
`the
`corresponding
`work remains
`time-consuming and labor-intensive. For
`the isolation of genes, which must precede functional
`study and characterization of
`the gene product,
`the
`flow of information is in most cases from isolated RNA
`
`libraries via
`(MRNA) via cDNA and appropriate gene
`complicated screening methods
`to a4 single clone. The
`desired DNA which has been cloned in said clone is
`
`freguently
`
`incomplete,
`
`so
`
`that
`
`further
`
`screening
`
`processes follow.
`
`DNA
`of
`recombination
`above-described
`the
`Finally,
`allows,
`has only limited flexibility and
`fragments
`together with the described amount of work required,
`only few opportunities for optimization.
`In view of the
`variety and complexity in genetics,
`functional genomics
`and proteomics,
`i.e.
`the study of gene product actions,
`such optimizations in particular are a bottleneck for
`the further development of modern biology.
`
`A common method is recombination by enzymatic methods
`{in vitro): here,
`DNA elements
`(isolated genomic DNA,
`
`

`

`CA 02362939 2001-08-13
`
`~3-
`
`4
`
`genomes,
`bacterial
`or
`viral
`amplicons,
`plasmids,
`vectors) are first cut into fragments with defined ends
`by appropriate restriction enzymes. Depending on the
`composition of these ends, it is possible to recombine
`the fragments
`formed and to link them to form larger
`DNA
`elements
`(likewise
`enzymatically) .-
`For
`DNA
`propagation purposes,
`this is frequently carried out
`in
`a plasmid acting as cloning vector.
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`to be propagated
`DNA normally has
`recombinant
`The
`clonally in suitable organisms
`(cloning)
`and,
`after
`this time-consuming step and isolation by appropriate
`methods,
`is again available for manipulations such as,
`for example,
`recombinations. However,
`the restriction
`enzyme cleavage sites are a
`limiting factor
`in this
`method: each enzyme recognizes a specific sequence on
`the (double-stranded) DNA, which is between three and
`twelve nucleotide bases
`in length,
`depending on
`the
`particular
`enzyme,
`and
`therefore, according
`to
`statistical
`distribution,
`a
`particular - number
`of
`cleavage
`sites at which
`the
`DNA
`strand is
`cut
`is
`present on each DNA element. Cutting the treated DNA
`into defined fragments, which
`can
`subsequently be
`combined to give the desired sequence,
`is important for
`recombination.
`Sufficiently different
`and
`specific
`enzymes are available for
`recombination technology up
`to a limit of 10 - 30 kilo base pairs (kbp) of the DNA
`to be cut.
`In addition, preliminary work and commercial
`suppliers provide corresponding vectors which take up
`the
`recombinant
`DNA
`and
`allow cloning
`{and
`thus
`propagation
`and
`selection).
`Such
`vectors
`contain
`suitable cleavage sites for efficient recombination and
`integration.
`
`With increasing length of the manipulated DNA, however,
`the rules of statistics give rise to the problem of
`multiple and unwanted cleavage sites. The statistical
`average
`for
`an
`enzyme
`recognition
`sequence
`of
`6
`nuclectide bases
`is one cleavage site per 4000 base
`
`

`

`CA 02362939 2001-08-13
`
`-d4-
`
`one
`is
`it
`8 nucleotide bases
`for
`and
`(4°)
`pairs
`65,000
`(4°). Recombination using
`cleavage
`site per
`therefore
`is
`not particularly
`restriction enzymes
`Suitable for manipulating relatively large DNA elements
`
`(e.g. viral genomes, chromosomes, etc.).
`
`recombination in cells is
`Recombination by homologous
`known,
`too. Here,
`if identical
`sequence sections are
`present on the elements
`to be
`recombined,
`it
`is
`possible to newly assemble and manipulate relatively
`large DNA elements by way of
`the natural process of
`homologous
`recombination. These
`recombination events
`are substantially more indirect than in the case of the
`restriction enzyme method and, moreover, more difficult
`to control. They often give distinctly poorer yields
`than
`the
`above-described
`recombination
`using
`
`restriction enzymes.
`
`A second substantial disadvantage is restriction to the
`identical sequence sections mentioned which, on the one
`hand, have to be present
`in the first place and, on the
`other
`hand,
`are
`very
`specific
`for
`the particular
`system.
`The
`specific
`introduction
`of
`appropriate
`sequences itself then causes considerable difficulties.
`
`An additional well-known method is the polymerase chain
`reaction (PCR) which allows
`enzymatic
`DNA synthesis
`(including high-multiplication)
`due
`to the bordering
`regions of
`the section to be multiplied indicating a
`DNA replication start by means of short,
`completely
`synthetic DNA oligomers
`(“primers”). For this purpose,
`however,
`these flanking regions must be known and be
`specific
`for
`the
`region
`lying
`in
`between. When
`replicating the
`strand,
`however,
`polymerases
`also
`incorporate
`wrong
`nucleotides,
`with
`a
`frequency
`depending on the particular enzyme,
`so that
`there is
`always
`the
`danger of
`a certain distortion of
`the
`starting sequence. For
`some applications,
`this gradual
`distortion can
`be very disturbing. During
`chemical
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`
`
`

`

`CA 02362939 2001-08-13
`
`- 5 -
`
`the above-
`for example,
`sequences such as,
`Synthesis,
`can
`be
`restriction
`cleavage
`sites
`described
`(limited)
`incorporated into the primers. This allows
`manipulation of
`the complete sequence. The multiplied
`region can now be in the region of approx.
`30 kbp, but
`most of this DNA molecule is the copy of a DNA already
`present.
`
`The primers are prepared using automated solid phase
`synthesis
`and are
`widely
`available,
`but
`the
`configuration of all automatic synthesizers
`known
`to
`date leads to the production of amounts of primer DNA
`(amol~range reaction mixtures) which are too large and
`not
`required for PCR, while the variety in variants
`remains limited.
`
`Synthetic DNA elements
`(inter alia in:
`Since the pioneering work of Khorana
`Shabarova: Advanced Organic Chemistry of Nucleic Acids,
`VCH Weinheim;)
`in the 1960s,
`approaches
`in order
`to
`assemble double-stranded DNA with genetic or
`coding
`sequences
`from chemically synthesized DNA molecules
`have repeatedly been described. State of the art here
`is genetic elements of up to approx.
`2 kbp in length
`which
`are
`synthesized from nucleic acids. Chemical
`solid phase synthesis of nucleic acids and peptides has
`been automated. Appropriate methods
`and devices have
`been
`described,
`for
`example,
`in
`US 4353989
`and
`US 5112575.
`
`short
`from
`synthesized
`is
`DNA
`Double-stranded
`(see
`to
`two methods
`according
`oligonucleotides
`PCR Methods and Applications, Cold
`Holowachuk et al.,
`Spring Harbor Laboratory Press):
`on the one hand, the
`complete double strand is synthesized by synthesizing
`Single-stranded nucleic acids (with suitable sequence),
`attaching complementary regions by hybridization and
`linking the molecular backbone by,
`for example,
`ligase.
`On
`the other hand,
`there is also the possibility of
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`

`

`CA 02362939 2001-08-13
`
`~6-
`
`as
`edges
`the
`overlapping
`regions
`synthesizing
`by
`attachment
`single-stranded
`nucleic
`acids,
`hybridization,
`filling in the single-stranded regions
`via enzymes
`(polymerases) and linking the backbone.
`
`at
`
`the genetic
`length of
`total
`the
`both methods,
`In
`element is restricted to only a few thousand nucleotide
`
`the expenditure and
`the one hand,
`on
`to,
`bases due
`production costs of nucleic acids in macroscopic column
`synthesis
`and,
`on
`the other hand,
`the logistics of
`nucleic acids being prepared separately in macroscopic
`column synthesis and then combined. Thus,
`the same size
`
`range as in DNA recombination technology is covered.
`
`a
`can be described as
`the prior art
`summarize,
`To
`procedure in which,
`in analogy to logical operations,
`the available matter
`(in this case genetic material
`in
`the form of nucleic acids)
`is studied and combined
`(recombination).
`The
`result
`of
`recombination
`experiments of
`this kind is then studied and allows
`
`the elements employed and
`inter alia about
`conclusions,
`their combined effect. The procedure may therefore be
`
`described as
`
`(selectively)
`
`analytical
`
`and
`
`combina-
`
`torial.
`
`The prior art
`studies
`of
`modification
`impossible.
`impossible.
`
`thus
`any
`of-
`the
`Systematic
`
`systematic
`allow any
`does not
`combinations
`whatsoever.
`The
`combined
`elements
`is
`almost
`testing of modifications is
`
`Subject of the invention and object achieved therewith
`It
`is
`intended to provide
`a method
`for directly
`
`converting
`
`digital
`
`genetic
`
`information
`
`(target
`
`into biochemical genetic
`etc.)
`databases,
`sequence,
`acids) without making
`use
`of
`(nucleic
`information
`nucleic acid fragments already present.
`
`
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`

`

`CA 02362939 2001-08-13
`
`-7-
`
`for
`a method
`to
`relates
`therefore
`invention
`The
`producing polymers,
`in which a plurality of oligomeric
`building blocks is synthesized on a support by parallel
`synthesis steps,
`is. detached from the support and is
`brought into contact with one another to synthesize the
`polymer. Preference is given to synthesizing double-
`stranded nucleic acid polymers of at
`least 300 bp,
`in
`particular at least 1000 bp in length. The nucleic acid
`polymers
`are preferably selected from genes,
`gene
`clusters,
`chromosomes, viral and bacterial genomes or
`
`sections thereof. The oligomeric building blocks used
`for
`synthesizing the
`polymer
`are preferably 5-150,
`particularly preferably 5-30, monomer units in length.
`In successive steps,
`it is possible to detach in each
`case partially complementary oligonucleotide building
`blocks from the support and to bring them into contact
`with one another or with the polymer intermediate under
`hybridization. conditions. Further examples of suitable
`polymers are nucleic acid analogs and proteins.
`
`the invention
`In a particularly preferred embodiment,
`relates to a method for producing synthetic DNA of any
`optional
`sequence
`and
`thus
`any
`known
`or
`novel
`functional genetic elements which are contained in said
`sequence. This method comprises the steps
`(a)
`provision of a support having a surface area which
`contains a plurality of individual reaction areas,
`location-resolved
`synthesis
`of
`nucleic
`acid
`fragments
`having
`in each
`case different
`base
`sequences
`in several of
`the individual
`reaction
`areas, and
`detachment of
`
`(b)
`
`(c)
`
`the nucleic
`
`acid fragments
`
`from
`
`individual reaction areas.
`
`fragments
`acid
`the nucleic
`of
`sequences
`The base
`synthesized in individual reaction areas are preferably
`chosen such that
`they can assemble to form a nucleic
`acid double strand hybrid. The nucleic acid fragments
`can then be detached in step {c)
`in one or more steps
`
`i0
`
`15
`
`20
`
`25
`
`30
`
`35
`
`

`

`CA 02362939 2001-08-13
`
`- 8 -
`
`under conditions such that
`a plurality,
`i.e. at
`least
`some of the detached nucleic acid fragments assemble to
`form a nucleic acid double strand hybrid. Subsequently,
`the nucleic acid fragments
`forming one strand of
`the
`
`nucieic
`
`acid
`
`double
`
`strand
`
`hybrid
`
`can
`
`at
`
`least
`
`partially be linked covalently to one another. This may
`be carried out
`by enzymatic
`treatment,
`for
`example
`using ligase, or/and filling in gaps
`in the strands
`
`using DNA polymerase.
`
`The method comprises within the framework of a modular
`system the synthesis of very many individual nucleic
`acid strands which serve as building blocks and, as a
`
`a double-stranded nucleic acid sequence which
`result,
`can
`be more
`than 100,000 base pairs
`in length is
`generated,
`for
`example
`in a microfluidic
`reaction
`support.
`
`acid which
`nucleic
`synthetic
`complex
`highly
`The
`preferably consists of DNA is produced according to the
`method and according to the following principle: first,
`relatively short
`DNA
`strands
`are
`synthesized in a
`Multiplicity of reaction areas on a reaction support by
`in situ synthesis. This may take place,
`for example,
`using the supports described in the patent applications
`DE 199 24 327.1,
`DE
`199 40 749.5,
`PCT/EP99/06316 and
`PCT/EP39/06317.
`In this connection,
`each reaction area
`is suitable for.-the individual and specific synthesis
`of an individual given DNA sequence of approx. 10 - 100
`
`form the
`strands
`DNA
`in length. These
`nucleotides
`building blocks for the specific synthesis of very long
`DNA molecules. The fluidic microprocessor used here may
`carry
`reaction
`spaces
`specially designed
`for
`the
`application.
`
`by
`carried out
`thus
`is
`itself
`synthesis
`DNA
`The
`following the automated solid phase synthesis but with
`some novel aspects:
`the “solid phase” in this case is
`an
`individual
`reaction area on
`the surface of
`the
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`
`
`

`

`CA 02362939 2001-08-13
`
`-9-
`
`the reaction space,
`for example the wall of
`support,
`i.e.
`it is not particles introduced into the reaction
`Space as
`is the case in a conventional synthesizer.
`Integration of the synthesis in a microfluidic reaction
`support
`(e.g.
`a
`structure with optionally branched
`channels
`and reaction spaces) makes
`it possible ta
`introduce the reagents
`and other
`components
`such as
`
`enzymes.
`
`the synthesized building blocks are
`After synthesis,
`detached from said reaction areas. This
`detachment
`process may be carried out
`location- or/and time-
`specifically
`for
`individual,
`several
`or
`all
`DNA
`strands.
`
`In a preferred variant of the method it is provided for
`a plurality of
`reaction areas to be established and
`utilized within a fluidic space or compartment so that
`the DNA strands synthesized therein can be detached in
`one operation step and taken away from the compartment
`which fluidically connects the reaction areas.
`.
`
`Subsequently, suitable combinations of the detached DNA
`strands
`are
`formed. Single-stranded or/and double-
`stranded building blocks
`are
`then
`assembled,
`for
`example, within a reaction space which may comprise one
`oer more reaction areas for the synthesis. Expediently,
`the
`sequence of the individual building blocks
`is
`chosen such that, when bringing the individual building
`blocks
`into
`contact with
`one
`another,
`regions
`complementary to one another are available at
`the two
`ends brought
`together,
`in order
`to make possible
`specific
`attachment
`of
`further
`DNA
`strands
`by
`hybridizing said regions. As
`a
`result,
`longer DNA
`hybrids are formed. The phosphorus diester backbone of
`these DNA hybrids may be covalently closed, for example
`by ligases, and possible gaps in the double strand may
`be filled in in a known manner enzymatically by means
`of polymerases. Single-stranded regions which may be
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`

`

`CA 02362939 2001-08-13
`
`- 10 -
`
`(e.g. Klenow
`enzymes
`filled in by
`be
`present may
`fragment) with the addition of suitable nucleotides.
`Thus
`longer
`DNA molecules
`are
`formed.
`By bringing
`together clusters of DNA strands synthesized in this
`
`is in turn possible to
`way within reaction spaces it
`generate
`longer part
`sequences
`of
`the
`final
`DNA
`molecule. This may be done
`in stages,
`and the part
`
`longer DNA
`to give ever
`together
`sequences are put
`molecules.
`In this way it is possible to generate very
`long DNA sequences as completely synthetic molecules of
`more than 100,000 base pairs in length.
`
`is
`individual building bliocks which
`amount of
`The
`long synthetic DNA molecule is dealt
`required for a
`with in the reaction support by parallel synthesis of
`the building blocks in a location- or/and time-resolved
`synthesis process.
`In the preferred embodiment,
`this
`parallel synthesis is carried out by light-dependent
`lecation-
`or/and time-resolved DNA
`synthesis
`in a
`fluidic microprocessor which is also described in the
`patent applications DE 199 24 327.1, DE 199 40 749.5,
`PCT/EP99/06316 and PCT/EP99/06317.
`,
`
`19
`
`15
`
`20
`
`a
`causes
`here
`support
`reaction
`The miniaturized
`reduction in the amount of starting substances by at
`
`25
`
`least a factor of 1000 compared with a conventional DNA
`synthesizer. At the same time, an extremely high number
`ef nucleic acid double strands of defined sequence is
`produced. Only in this way is it possible to generate a
`very large variety of individual building blocks, which
`is required for the synthesis of long DNA molecules, by
`using an economically sensible amount of resources. The
`synthesis of a sequence of 100,000 base pairs, composed
`of overlapping building blocks of
`20 nucleotides in
`length,
`requires
`10,000
`individual building blocks.
`This can be achieved using appropriately miniaturized
`equipment in a highly parallel synthesis process.
`
`30
`
`35
`
`

`

`CA 02362939 2001-08-13
`
`~ 11 -~
`
`'
`
`For efficient processing of genetic molecules
`systematic inclusion of all possible variants
`it
`
`and
`is
`
`necessary to produce
`
`the
`
`individual building block
`
`sequences
`
`in a
`
`flexible and economic way. This
`
`achieved
`
`by
`
`the method
`
`preferably
`
`by
`
`using
`
`is
`
`a
`
` light-
`the
`for
`source matrix
`light
`programmable
`situ
`in
`or/and
`time-resolved
`dependent
`location-
`synthesis of the DNA strands, which in turn can be used
`
`DNA
`longer
`the synthesis of
`for
`as building blocks
`free
`strands.
`This
`flexible
`synthesis
`allows
`programming of the individual building block sequences
`and thus also generation of any variants of
`the part
`
`sequences or
`
`the final sequence, without
`
`the need for
`
`components
`substantial modifications
`of
`system
`the building
`(hardware). This programmed synthesis of
`blocks and thus the final synthesis products makes it
`
`to systematically process
`possible
`the variety of
`elements. At
`genetic
`the same
`time,
`the
`use
`of
`computer-controlled
`programmable
`synthesis . allows
`automation
`of
`the
`entire
`process
`including
`communication with appropriate databases.
`
`With
`
`a given target
`
`sequence,
`
`the sequence of
`
`the
`
`individual building blocks can be selected efficiently,
`
`taking
`into
`account
`biochemical
`and
`functional
`parameters. After putting in the target sequence (e.g.
`from a database),
`an
`algorithm makes out
`suitable
`overlapping regions. Depending on the task, different
`amounts of
`target
`sequences
`can be produced, either
`within one reaction support or spread over a plurality
`of reaction supports. The hybridization conditions for
`
`formation
`
`of
`
`the
`
`hybrids,
`
`such
`
`as,
`
`for
`
`example,
`
`temperature, salt concentrations, etc., are adjusted to
`
`10
`
`15
`
`20
`
`25
`
`30
`
`by
`regions
`overlap
`available
`the
`algorithm.
`Thus, maximum attachment
`
`appropriate
`an
`specificity is
`
`35
`
`ensured.
`
`In a
`
`fully automatic version,
`
`it
`
`is
`
`also
`
`sequence data directly from
`possible to take target
`public or private databases
`and
`convert
`them into
`appropriate target
`sequences. The products generated
`
`

`

`CA 02362939 2001-08-13
`
`- 32 -
`
`may in turn be introduced optionally into appropriately
`automated processes,
`for
`example
`into
`cloning
`in
`suitable target cells.
`
`.
`
`Synthesis in stages by synthesizing the individual DNA
`strands
`in reaction areas within enclosed reaction
`
`difficult
`of
`synthesis
`the
`allows
`also
`spaces
`repeats of
`sequences,
`for example those with internal
`sequence
`sections,
`which
`occur,
`for
`example,
`in
`retroviruses and corresponding retroviral vectors. The
`controlled detachment of building blocks within the
`fluidic
`reaction spaces makes
`a
`synthesis
`of
`any
`sequence possible, without problems being generated by
`assigning the overlapping regions
`on
`the individual
`building blocks.
`
`for
`necessary
`requirements
`.quality
`high
`The
`inter
`synthesizing very long DNA molecules can be met
`alia by using real-time quality control. This comprises
`monitoring
`the
`location-resolved
`building
`block
`
`synthesis,
`
`likewise
`
`detachment
`
`and
`
`assembly ‘up
`
`to
`
`production of
`
`the final
`
`sequence. Then all processes
`
`take place
`
`in a
`
`transparent
`
`reaction support.
`
`In
`
`10
`
`15
`
`20
`
`addition,
`
`the possibility to follow reactions
`
`25
`
`fluidic
`
`processes
`
`in
`
`transmitted
`
`light meade,
`
`and
`
`for
`
`example by CCD detection,
`
`is created.
`
`preferably
`is
`support
`The Miniaturized .. reaction
`designed such that a detachment process is possible in
`
`30.
`
`the individual reaction spaces and thus the DNA strands
`
`synthesized on the reaction areas located within these
`
`reaction
`clusters.
`
`spaces
`In a
`
`in
`or
`individually
`detached
`are
`suitable embodiment of
`the reaction
`
`35
`
`support it is pessible to assemble the building blocks
`in reaction spaces in a process in stages and also to
`remove building blocks, part
`sequences or
`the
`final
`product or else to sort or fractionate the molecules.
`
`
`
`

`

`CA 02362939 2001-08-13
`
`-~13-
`
`completion, may be
`its
`after
`sequence,
`target
`The
`introduced as integrated genetic element
`into cells by
`transfer
`and
`thereby
`be
`cloned
`and
`studied
`in
`functional. studies. Another possibility is to firstly
`further purify or
`analyze
`the
`synthesis product,
`a
`possible example of said analysis being sequencing. The
`sequencing process may also be
`initiated by direct
`coupling using an appropriate apparatus,
`for example
`using a device described in the patent applications DE
`199 24 327.1,
`DE
`199 40 749.5,
`PCT/EP99/06316
`and
`PCT/EP99/06317
`for
`the
`integrated
`synthesis
`and
`analysis of polymers.
`It
`is likewise conceivable to
`isolate and analyze the generated target sequences
`after cloning.
`
`The method of the invention provides via the integrated
`genetic elements generated therewith a tool which,
`for
`the further development of molecular biology,
`includes
`biological
`variety
`in
`a
`systematic
`process.
`The
`generation
`of
`DNA molecules with desired genetic
`information
`is
`thus
`no
`longer
`the bottleneck of
`molecular biological work,
`since all molecules,
`from
`small plasmids via complex vectors to mini chromosomes,
`can be generated synthetically and are available for
`further work.
`
`The production method allows generation of numerous
`different nucleic acids and thus a systematic approach
`for
`questions
`concerning
`regulatory elements,
`DNA
`binding
`sites
`for
`regulators,
`signal
`cascades,
`receptors, effect and interactions of growth factors,
`etc.
`
`fully
`into a
`elements
`integration of genetic
`The
`it possible to
`synthetic complete nucleic acid makes
`further utilize known genetic tools such as plasmids
`and vectors
`and
`thus
`to
`build
`on
`the
`relevant
`experience. On
`the other hand,
`this experience will
`change rapidly as a result of the intended optimization
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`
`
`

`

`CA 02362939 2001-08-13
`
`-~ 14 -
`
`of available vectors, etc. The mechanisms which,
`
`for
`
`example, make a plasmid suitable for propagation ina
`particular cell type can be studied efficiently for the
`first time on the basis of the method of the invention.
`
`This efficient study of large numbers of variants makes
`it possible to detect
`the entire combination space of
`genetic elements. Thus,
`in addition to the at
`the
`moment
`rapidly developing
`highly parallel
`analysis
`{inter alia on DNA arrays or DNA chips),
`the programmed
`synthesis of integrated genetic elements is created as
`a second important element. Only both elements together
`can
`form the
`foundation of
`an efficient molecular
`
`biology.
`
`The programmed synthesis of appropriate DNA molecules
`makes possible not only random composition of
`the
`coding
`sequences
`and
`functional
`elements
`but
`also
`adaptation
`of
`the’
`intermediate
`regions. This may
`rapidly lead to minimal vectors and minimal genomes,
`whose
`small size in turn generates advantages. As
`a
`result,
`transfer vehicles such as,
`for example, viral
`
`vectors can be made more efficient,
`using retroviral or adenoviral vectors.
`
`for example when
`
`In
`
`addition
`
`to
`
`the
`
`combination
`
`of
`
`known
`
`genetic
`
`is possible to develop novel genetic
`it
`sequences,
`elements which can build on the function of available
`elements. Especially for
`such developmental work,
`the
`flexibility of the system is of enormous value.
`
`the
`The synthetic DNA molecules are in each stage of
`development
`oof
`the method
`described
`here
`fully
`compatible with the available recombination technology.
`For “traditional” molecular biological applications it
`is
`also
`possible
`to
`provide
`integrated
`genetic
`elements,
`for
`example
`by
`appropriate
`vectors.
`Incorporation of appropriate cleavage sites even of
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`
`
`

`

`CA 02362939 2001-08-13
`
`- 15 -
`
`enzymes little used so far is not a limiting factor for
`integrated genetic elements.
`
`Improvements in comparison with prior art
`This method makes it possible to integrate all desired
`functional elements as “genetic modules” such as,
`for
`example, genes, parts of genes,
`regulatory elements,
`viral packaging signals,
`etc.
`into the
`synthesized
`nucleic
`acid molecule
`as
`carrier
`of
`genetic
`information. This integration leads to inter alia the
`following advantages:
`
`extremely
`therewith
`develop
`to
`possible
`is
`It
`functionally integrated DNA molecules, unnecessary DNA
`regions being removed (minimal genes, minimal genomes).
`
`the genetic elements and also
`free combination of
`The
`modifications of the sequence such as,
`for example,
`for
`‘adaptation to the expressing organism or cell type
`(codon
`usage)
`are
`made
`possible
`as. well
`as
`modifications of the sequence for optimizing functional
`genetic
`parameters
`such
`as,
`for
`example,
`gene
`regulation.
`
`Modifications of the sequence for optimizing functional
`parameters of
`the transcript,
`for
`example
`splicing,
`regulation at
`the
`mRNA
`level,
`regulation at
`the
`translation level,..and, moreover,
`the optimization of
`functional parameters of the gene product,
`such as,
`for
`example,
`the
`amino
`acid sequence
`(e.g.
`antibodies,
`growth
`factors,
`receptors,
`channels,
`pores,
`transporters, etc.) are likewise made possible.
`
`the system created by the method is
`the whole,
`On
`extremely flexible and allows
`in a manner previously
`not
`available
`the
`programmed production of genetic
`material
`under
`greatly
`xreduced
`amounts of
`time,
`materials and work needed.
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`

`

`CA 02362939 2001-08-13
`
`- 16 -
`
`almost
`been
`has
`it
`available methods,
`the
`Using
`impossible to specifically manipulate relatively large
`DNA molecules of several
`hundred
`kbp,
`such
`as
`chroamesomes
`for
`example.
`Even more
`complex
`(i.e.
`larger)
`viral
`genomes
`cf more
`than
`30 kbp
`(e.g.
`adenoviruses) are difficult to handle and to manipulate
`
`using the classical methods of gene technology.
`
`The method of
`
`the invention leads
`
`to a considerable
`
`the
`shortening up to the last stage of cloning a gene:
`gene or
`the genes are synthesized as DNA molecule and
`then (after suitable preparation such as purification,
`etc.)
`introduced directly into target cells and the
`result
`is
`studied.
`The multi-stage cloning process
`which is mostly carried out
`in microorganisms such as
`E. coli
`(e.g.
`DNA isolation, purification,
`analysis,
`recombination,
`. cloning
`in
`bacteria,
`isolation,
`analysis, etc.) is thus reduced to the last transfer of
`the DNA molecule into the final effector cells. For
`
`synthetically produced genes or gene fragments clonal
`propagation in an intermediate host
`(usually E. coli)
`is no longer required. This avoids the danger of
`the
`gene product destined for the target cell exerting a
`toxic
`action on
`the
`intermediate host.
`This
`is
`
`some gene
`from the toxicity of
`distinctly different
`products, which, when using classical plasmid vectors,
`frequently leads to considerable problems
`for cloning
`of the appropriate nucleic acid fragments.
`
`is the reduction in
`Ancther considerable improvement
`time and the reduction in operational steps to after
`the
`sequencing of genetic material, with potential
`genes
`found
`being verified as
`such
`and
`cloned.
`Normally, after finding interesting patterns, which are
`possible open reading frames
`(ORF), probes are used
`(e.g. by means of PCR)
`to search in cDNA librari

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket